Oil Spoils The Open of a Major Earnings Week 🛢️

The market slipped Monday after war risk shoved oil higher and turned the AI trade into a funding-cost problem. It was a wild weekend for politics and war. Crude climbed nearly 10% as Trump said the U.S. blockade was coming back, complete with tolls.
Crude’s surge put energy on top and tech at the bottom, which is about as clean as rotation gets. The Fed did not help the mood either, with Christopher Waller warning that another hot core inflation print could put rate hikes back on the table right before Tuesday’s CPI print.
Stocktwits heat ran away from the index drivers and into the chaos trades: $QTTB ripped on alopecia data, $ORCL dip-buyers argued with debt bears, and $APP kept sliding as ad-growth worries hit the stream.
Today’s Briefing:
-
After the Bell: Big banks report Tuesday morning into a messy setup of CPI, rate risk, and credit-loss nerves
-
Stocks: Q32 Bio turned trial data into a monster rally, while Oracle’s 52-week low exposed the debt side of AI infrastructure
-
Macro News: Waller warned another hot inflation print could force the Fed to consider tightening again
-
Pops and Drops & More

AFTER THE BELL
Banks Take The Mic 🏦

It’s finally the start of the official earnings season tomorrow. JPMorgan Chase, Bank of America, Wells Fargo, and Citigroup report Tuesday morning, giving investors the first clean read on whether the financials rally has earnings behind it or just a better outfit. The setup is unusually crowded: five of the six largest U.S. banks report before the open, right as June CPI hits the tape.
The RIP: $JPM fell -0.6% Monday, with analysts expecting $5.59 EPS on $49.39B revenue. $BAC slipped -0.3%, with estimates near $1.12 EPS and $30.62B revenue. $WFC rose +0.6%, with $1.72 EPS on $21.85B revenue expected. $C was flat, with $2.67 EPS on $23.47B revenue expected.
The big test is not just whether banks beat. It is whether higher-for-longer rates, trading revenue, loan growth, and deal fees can offset deposit costs and credit-loss nerves.
JPMorgan is still the sector’s quality-control sample, Wells Fargo has the cleanest “beat-and-raise” options chatter, Bank of America is the rate-sensitive NII tell, and Citi remains the turnaround name with the most room to prove it is not just cheap for a reason. 🧾
The $JPM room is split on bank earnings, track the reaction ->
“$JPM best ‘boomer stock’ out there. Easily will double beat and raise” @SwingTradeMaestro
“$BAC Interest rates are the driver. If the yield curve normalizes, the net interest income will get a significant boost.” @RaphaelRex
SPONSORED BY TRADIER
Futures Just Hit Stocktwits – Powered by CME Group
Futures data is now live on Stocktwits, powered by CME Group, giving traders real-time access to global markets.
Tradier empowers you to act on that data with fast, reliable execution, extended trading hours, ultra-low commissions, and low capital requirements. With desktop, web, and mobile access, react in real time and explore new opportunities – all with the speed and flexibility active traders need.
Tradier is now offering 1 Year of TradingView Essential PLUS CME Futures market data when you open and fund a futures account.*
Explore new strategies, react in real time, and move with the markets – powered by CME Group, tradable on Tradier.
*The TradingView Futures promotion is available to new Tradier customers who register through this page and deposit at least $10,000 within 30 days of opening a Tradier Futures account. Qualified customers will receive 12 months of TradingView Essential and CME Level 1 market data at no cost, plus special Futures commission pricing equal to the Tradier Pro plan. After 12 months, standard rates for TradingView Essential and CME Level 1 market data (as listed on their respective websites) will apply. If you already have a TradingView Essential plan, you’ll receive 12 free months or a discount equal to its value toward your existing plan. To retain the complimentary plans, both the account and required balance must remain active for 12 months. Offer is non-transferable, cannot be combined with other promotions, and is limited to one account per customer or household. Tradier reserves the right to withhold or revoke the offer in cases of suspected fraud or abuse and to end the offer at any time. Before trading options, please read Characteristics and Risks of Standardized Options (https://www.theocc.com/company-information/documents-and-archives/options-disclosure-document). Supporting documentation for any claims, if applicable, will be furnished upon request.
*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
STOCKS
Q32 Grows Hair 🧬

Q32 Bio, a clinical-stage biotech developing immune-system drugs, ripped Monday after its alopecia treatment cleared a Phase 2a test. Then the company did what small biotechs do after a monster data-day rally: it used the spike to launch a stock sale.
The RIP: $QTTB surged +91% to $21.38 on Monday. Bempikibart reduced SALT scores by 35.3% in the modified intent-to-treat group, with 40% of patients hitting SALT-20. Q32 later announced a proposed $200M public offering plus a $30M underwriter option.
The data gives Q32 a real clinical story in severe alopecia areata, and analysts immediately moved targets higher, with Wells Fargo at $66, Mizuho at $36, and Oppenheimer at $40, according to Stocktwits chatter. But the offering turns the trade from “trial win” into “how much dilution,” especially with only about 17M shares outstanding before the raise. Biotech rallies are fun until the cap table starts doing math. 🧪
The $QTTB room is 81% bull on trial data, follow the fallout ->
“$QTTB price target upgraded Wells Fargo $66.X Mizuho : $36 Oppenheimer: $40” @R1cfla1rDr1p
“$QTTB began an underwritten public offering of $200 million in common stock and pre-funded warrants.” @focafoca99
AI’s Debt Hangover 🧾
Oracle, the enterprise software and cloud-infrastructure giant, got dragged into Monday’s AI hardware reset as investors started treating the buildout less like free growth and more like a financing problem. The networking stock, and AI build out giant hit a 52-week low as investors punished the industry. The same pressure hit networking and chip names tied to data-center demand, with Marvell and Astera Labs taking the nastier end of the move.
The RIP: $ORCL tumbled -6% Monday after S&P cut its credit rating to BBB-, one notch above junk. $MRVL dropped -8%, $ALAB fell -12%, $ARM slid -8%, $NVDA lost -4%, and $ANET declined -3%.
Oracle’s bull case is that its OpenAI and cloud backlog eventually turns into massive revenue. The problem is the market is now asking who pays for the data centers first, and Monday’s 52-week-low print says investors are not giving the balance sheet a free pass anymore. If Oracle cannot prove cash flow is catching up with capex, it risks being valued less like software and more like a debt-funded AI landlord. 🏗️
The $ORCL room is 68% bull on AI debt, get the debate ->
“$ORCL stock price is now lower than before it announced any deal with OpenAI.” @WeeklyOptionsTrading

MACRO NEWS
Waller Brings Heat 🔥
Fed Governor Christopher Waller warned Monday that another hot core inflation print could force the central bank to consider raising rates again. That lands right before June CPI, with oil climbing back on Middle East tension and traders suddenly remembering inflation is not a ghost story.
The RIP: Fed funds futures now price two quarter-point hikes by April 2027, with the first possible in October, up from one expected hike in December last week. May PCE rose 4.1%, May CPI hit 4.2%, June headline CPI is expected at 3.8%, and core CPI is expected at 2.9%.
“Sternly staring at inflation until it melts before our withering gaze is not an option,” Christopher Waller, Fed governor, said Monday. “If we get another hot reading on core inflation this week, then the FOMC will need to consider tightening monetary policy in the near term.” 🔥

TRENDING ON STOCKTWITS
Pops & Drops
$USO ( ▲ 8.36% ) United States Oil ⚡: surged +9% after Hormuz tensions lifted crude prices
$CRM ( ▲ 4.84% ) Salesforce: climbed +5% after software stocks caught an AI rotation bid
$CMG ( ▲ 3.92% ) Chipotle ⚡: popped +4% after bargain hunters tested oversold restaurant names
$CVX ( ▲ 3.29% ) Chevron: jumped +3% after crude strength pulled energy higher
$ONDS ( ▼ 4.13% ) Ondas ⚡: fell -4% after drone deal dilution worries lingered
$QXO ( ▼ 7.34% ) QXO ⚡: slid -7% after TopBuild deal dilution hit holders
$ARM ( ▼ 7.55% ) Arm: tanked -8% after chip stocks broke below key support
$MRVL ( ▼ 7.75% ) Marvell: dropped -8% after high-beta chip names kept unwinding
$SNDK ( ▼ 12.63% ) Sandisk: cratered -13% after SK Hynix sparked memory-chip profit-taking
$APP ( ▼ 12.65% ) AppLovin ⚡: collapsed -13% after BofA flagged slower e-commerce ad growth


ST EDITOR’S PICKS
Links That Don’t Suck 🌐
📈 ORCL Eyes 52-Week Low After Sharp Slide: Retail Traders Say Stock Is ‘Ridiculously Undervalued’
😨 US will blockade Iran in the Strait of Hormuz and charge ships for safe passage
💰️ Inflation is primed to fall for the first time in 6 years. Will high prices drop too?
Kill Chain: On the automated bureaucratic machinery that killed 175 children

WHAT’S ON DECK
Tomorrow’s Top Things 📋
Macro: Consumer Price Index (CPI) (8:30 AM ET). 📊
Pre-Market Earnings: $BAC Bank Of America Corp., $JPM JPMorgan Chase & Co., $WFC Wells Fargo & Co., $C Citigroup Inc, $GS Goldman Sachs Group, Inc., +3 more. ☀️
After-Market Earnings: $AEHR Aehr Test Systems, $NTRP NextTrip Inc., $FNGR FingerMotion Inc. 🌙
P.S. You can listen to all of these earnings calls on Stocktwits.

Terms & Conditions 📝
Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The content is to be used for informational and entertainment purposes only and the service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which content is published on the service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍
Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋


